Beryl Drugs has informed that the Board of the Directors of the Company at its meeting held on July 11, 2016, has considered and approved the Directors Report for the financial year ended on March 31, 2016; Book Closure Notice and fixed the cut -off date for entitlement of Voting Rights of Member for remote E-Voting; 23rd Annual General Meeting Notice and directed to dispatch the Notice to the Shareholders; authorized Directors of the Company to authenticate and file forms under Companies Act, 2013 on behalf of the Company.
The above information is a part of company’s filings submitted to BSE.